塑化剂迁移量测定和迁移模型研究进展

综述国内外塑化剂迁移量测定和迁移模型研究进展,从创新实验测定方法和实验误差分析的角度简要评述了迁移量测定的研究成果;从数学模型的角度对微分方程模型、统计模型和计算机模拟3类重要迁移模型进行评述。最后指出,测定实验和迁移模型相结合来研究塑化剂迁移问题是未来一个值得重视的方法。     

基于G-四链体模板的银纳米簇共振能量转移比率检测miRNA

以DNA为模板合成的荧光银纳米簇（DNA-Ag NC）是一类性能优秀的发光探针,已被广泛应用于传感与成像领域.目前大多数定量方法都是基于目标物结合带来的直接的银纳米簇发光强度的变化,因此,分析方法的重现性将不可避免地受实验场地或测定条件变化的影响.本工作中,采用以G-四链体为模板的银纳米簇（GQ-Ag NC）与菁染料Cyanine5（Cy5）为能量供-受体对,发展了基于荧光共振能量转移（FRET）机理的miRNA比率测定方法.其中,Cy5标签具有通用性,简化了实际应用中的实验设计,降低了试剂成本.针对miRNA let-7a的方法,检测动态范围为12~300 nmol/L,检测限为6.9 nmol/L,且可以将let-7a与let-7家族中的其他miRNA区分.HepG2细胞的总RNA提取物加标回收结果表明该方法具有应用于临床样本测试的潜力.本研究工作拓展了DNA-Ag NC的应用,并有助于加深在FRET设计中以DNA-Ag NC为供体进行分析应用的进一步理解.     

甲烷浓度对碳化硅基底金刚石薄膜摩擦性能影响

利用热丝化学气相沉积法(HFCVD)在碳化硅基底上制备金刚石薄膜,采用场发射扫描电子显微镜、拉曼光谱仪、原子力显微镜研究了在不同甲烷浓度条件下制备的金刚石薄膜表面形貌及物相组成,在干摩擦条件下通过往复式摩擦磨损实验测试并计算了已制备金刚石薄膜的摩擦系数和磨损率,结合物相分析及摩擦磨损实验结果分析了甲烷浓度的改变对金刚石薄膜摩擦磨损性能的影响。结果表明,由于甲烷气体含量的升高,金刚石薄膜结晶质量下降,薄膜由微米晶向纳米晶转变。摩擦磨损实验结果显示:3%甲烷浓度条件下制备的金刚石薄膜耐磨性较好,磨损率为2.2×10^-7 mm³/mN;5%甲烷浓度条件下制备的金刚石薄膜摩擦系数最低(0.032),磨损率为5.7×10^-7 mm³/mN,制备的金刚石薄膜的耐磨损性能相比于碳化硅基底(磨损率为9.89×10^-5 mm³/mN)提升了两个数量级,显著提高了碳化硅基底的耐磨性。     

Surface plasmon resonance imaging for affinity analysis of aptamer–protein interactions with PDMS microfluidic chips

We report on the use of PDMS multichannels for affinity studies of DNA aptamer–human Immunoglobulin E (IgE) interactions by surface plasmon resonance imaging (SPRi). The sensing surface was prepared with thiol-terminated aptamers through a self-assembling process in the PDMS channels defined on a gold substrate. Cysteamine was codeposited with the thiol aptamers to promote proper spatial arrangement of the aptamers and thus maintain their optimal binding efficiencies. Four aptamers with different nucleic acid sequences were studied to test their interaction affinity toward IgE, and the results confirmed that aptamer I (5′-SH-GGG GCA CGT TTA TCC GTC CCT CCT AGT GGC GTG CCC C-3′) has the strongest binding affinity. Control experiments were conducted with a PEG-functionalized surface and IgG was used to replace IgE in order to verify the selective binding of aptamer I to the IgE molecules. A linear concentration-dependent relationship between IgE and aptamer I was obtained, and a 2-nM detection limit was achieved. SPRi data were further analyzed by global fitting, and the dissociation constant of aptamer I–IgE complex was found to be 2.7 × 10⁻⁷ M, which agrees relatively well with the values reported in the literature. Aptamer affinity screening by SPR imaging demonstrates marked advantages over competing methods because it does not require labeling, can be used in real-time, and is potentially high-throughput. The ability to provide both qualitative and quantitative results on a multichannel chip further establishes SPRi as a powerful tool for the study of biological interactions in a multiplexed format. Figure The SPRi sensograms and thier global fits for aptamer I and IgE interactions. Insert in the difference image obtained with the PDMS microchannel flow cell for aptamer IV, III, and I (from left to right     

Self‐assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer

DNA damage repair through the nucleotide excision repair (NER) pathway is one of the major reasons for the decreased antitumor efficacy of platinum‐based anticancer drugs that have been widely applied in the clinic. Inhibiting the intrinsic NER function may enhance the antitumor activity of cisplatin and conquer cisplatin resistance. Herein, we report the design, optimization, and application of a self‐assembled lipid nanoparticle (LNP) system to simultaneously deliver a cisplatin prodrug together with siRNA targeting endonuclease xeroderma pigmentosum group F (XPF), a crucial component in the NER pathway. The LNP is able to efficiently encapsulate both the platinum prodrug and siRNA molecules with a tuned ratio. Both platinum prodrug and XPF‐targeted siRNA are efficiently carried into cells and released; the former damages DNA and the latter specifically downregulates both mRNA and protein levels of XPF to potentiate the platinum drug, leading to enhanced expression levels of apoptosis markers and improved cytotoxicity in both cisplatin‐sensitive and ‐resistant human lung cancer cells. Our results demonstrate an effective approach to utilize a multi‐targeted nanoparticle system that can specifically silence an NER‐related gene to promote apoptosis induced by cisplatin, especially in cisplatin‐refractory tumors.     

一种含有亚微米孔洞的新型微孔磷酸盐晶体材料的合成及其生长机理

采用水热法成功地合成了一种含有亚微米级孔洞的微孔磷酸盐晶体材料(记为HAP-TAP),其形貌特征是:六棱柱形的晶体表面分布着大量0.4～0.8μm的亚微米级孔洞,孔洞内长有片层状晶体.在样品晶化的过程中,通过控制合成时间,获得了纯六棱柱形晶体的大单晶(记为HAP).使用扫描电子显微镜(SEM)、粉末X射线衍射(XRD)、红外光谱和电子能谱(EDX)对HAP-TAP独特形貌的形成机理进行了研究和揭示.HAP的单晶XRD数据表明,HAP是一种具有二维空旷骨架结构的新型微孔磷酸铝晶体,其分子式为Al5(OH)2(PO4)7(C2N2H10)3.0.5H2O.EDX分析结果表明,生长于六棱柱形晶体孔洞内的片层状晶体为磷酸钛铝材料.     

血清CLDN5、OCLN和ZO1与颅脑损伤急性期患者损伤程度及预后的关系

目的探讨非开放性颅脑损伤急性期患者血清中封闭蛋白5（CLDN5）、密封蛋白（OCLN）和紧密连接蛋白1（ZO1）的含量与患者损伤严重程度及预后的关系。方法收集2014年2月至2015年2月非开放性颅脑损伤急性期患者92例。患者入院后立即留取外周血,检测血清中CLDN5、OCLN和ZO1的含量,分析三者与患者格拉斯哥昏迷评分（GCS）、颅内血肿体积的关系以及对患者预后的判断价值。结果不同GCS的患者间血清CLDN5和OCLN含量均有统计学差异（均P＜0.05）;不同血肿体积的患者间CLDN5和OCLN含量均有统计学差异（均P＜0.05）;死亡患者的血清CLDN5和OCLN含量明显高于存活组（均P＜0.05）,在不同GCS、血肿体积和预后的患者间比较,ZO1含量均无统计学差异（均P＞0.05）。GCS与血清CLDN5、OCLN含量均呈负相关（rCLDN5=-0.84,rOCLN=-0.85,均P＜0.01）,与ZO1无相关性（rZO1=0.14,P＞0.05）;血肿体积与血清CLDN5、OCLN和ZO1含量均呈正相关（rCLDN5=0.82,rOCLN=0.93,rZO1=0.82,均P＜0.01）。结论血清CLDN5、OCLN可以作为急性颅脑损伤患者病情严重程度和预后判断的有效生物标志物。     

计及风和湍流的热晕及其相位补偿的数值研究

本工作用包括热晕、湍流和风等效应的等压近似下四维激光传输程序，数值计算了激光大气传输中的整束热畸变效应及其理想相位补偿，得到了各种情况下的激光大气传输畸变图象，并分析了热晕和湍流的相互作用。另外，还讨论了时、空步长的选取原则。     

在线固相萃取和高效液相色谱法测定卷烟主流烟气中几种芳胺

研究了用在线固相萃取富集和高效液相色谱法测定卷烟主流烟气中的几种芳胺(苯胺、对甲基苯胺、2,4-二甲基苯胺、1-萘胺、2-萘胺和4-氨基联苯)的方法,样品中的芳胺用邻甲氧基酚衍生生成偶氮染料,偶氮染料用WatersXterraTMRP18色谱柱在线固相萃取富集,然后以WatersXterraTMRP18色谱柱为固定相,75%的甲醇(内含0.01mol/LpH=8的四氢吡咯-醋酸缓冲液)为流动相分离,二极管矩阵检测器检测;苯胺、对甲基苯胺、2,4-二甲基苯胺、4-氨基联苯、1-萘胺、2-萘胺的检出限分别为005、0.08、0.08、0.06、0.03和0.03μg/L。几种芳胺的相对标准偏差在2.2%~3.4%之间;标准回收率在89%~106%之间,方法用于卷烟主流烟气中几种芳胺的测定,结果令人满意。     

槲皮素-3-O-丙基衍生物的合成及生物活性研究

槲皮素是具有丰富生物活性的黄酮类化合物,药理活性显著。本文以槲皮素为先导物,选择性对C环3位羟基进行修饰,以廉价的芦丁为原料,经苄基保护、Williamson成醚反应,再经Pd/C催化加氢脱苄基得到28个未见文献报道的槲皮素-3-O-丙基衍生物,其结构经¹H NMR、¹³C NMR、ESI-MS进行确证。采用MTT法考察了所合成化合物对人食管鳞癌（EC109）、人胃癌（HGC27）、人乳腺癌（MCF-7）、小鼠黑色素瘤（B16-F10）的增殖抑制作用。结果显示,通过化学方法对槲皮素结构进行修饰后,其体外抗肿瘤活性增强。其中,化合物F3(IC₅₀=5.23±0.37μmol/L)、F5(IC₅₀=2.63±0.09μmol/L)对小鼠黑色素瘤（B16-F10）抑制作用比5-氟尿嘧啶(IC₅₀=14.38±0.27μmol/L)好,值得进一步研究。